We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Events

25 Jun 2026 - 27 Jun 2026
02 Jul 2026 - 04 Jul 2026
08 Jul 2026 - 10 Jul 2026

Abbott and Cerner to Develop Safer Infusion System

By HospiMedica staff writers
Posted on 15 May 2003
An exclusive agreement to develop and co-market a safer new point-of-care (POC) medication-management system for infusion therapy has been announced by Abbott Laboratories (Abbott Park, IL, USA) and Cerner Corp. More...
(Kansas City, MO, USA).

The system will integrate POC infusion and diagnostic medical devices, bar coding, clinical information, and decision-support tools at the patient's bedside to improve safety, clinical outcomes, and cost management. Initially, the system will aim to improve safety in fusion therapy through a secure identification of the caregiver, patient, device, and IV access site matched with doctor orders, patient-assessment parameters, patient medical history, and hospital-specific best-practice treatment protocols. The system will then be enhanced to include Cerner's software, called Cerner Millennium solutions.

These solutions comprise an integration tool kit, a drug information database, computerized doctor-order entry system, pharmacy information system, and electronic medical record. These will be combined with Abbot's POC diagnostic devices, including its infusion therapy pumps. The system will interface with most hospital information systems and medical devices. Additional functionality may be added for more complex therapeutic applications and clinical specialties.

"The collaboration between our two companies will accelerate the development of software products that provide solutions for therapies with the highest potential for error,” said John Arnott, vice president, hospital business sector, Abbott.





Related Links:
Abbott
Cerner Corp

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Pediatric Mask
Respire SOFT
Rapid Sepsis Test
SeptiCyte RAPID
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Conceptual schematic of MEND in combination with eCPCs for laryngotracheal reconstruction (Gehret, P., Ali Akbari Ghavimi, S., Dumas, A.A. et al.Nature Communications (2026). DOI: 10.1038/s41467-026-73680-2)

Personalized Cartilage Graft Offers New Option for Infants with Severe Airway Narrowing

Severe subglottic stenosis is a narrowing of the airway below the vocal cords and above the trachea. The condition can leave infants dependent on tracheostomy while awaiting reconstructive surgery to enable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.